An Investigation Of The Effects Of Inoculated And Intralymphatic Vaccinia Virus On Primary And Secondary Deposits Of Malignant Melanoma

The six patients included in this investigation were selected on the basis of histologically-proven malignant melanomas of the lower extremity, with either local intradermal metastases or regional lymph node involvement. If unvaccinated in the previous five years, vaccination was performed at least 14 days before using the virus therapeutically. Vaccinia virus was prepared from stock vacccine obtained from the South African Institute for Medical Research. Virus was inoculated on the Chorio-allantoic membrane of 12 day embryonated hens’ eggs in which growth was confluent on the third day. Virus was extracted in buffered saline, cleared and tested for sterility. The titre of the undiluted material was 107 pock forming units per ml. This was used at a dilution of 1:50 for both the superficial and deep lesions.

A CAJM investigation of the Effects of Inoculated and Intralymphatic Vaccinia Virus on Primary and Secondary Deposits of Malignant Melanoma.